Effect of Blood Glucose Concentrations on Admission in Non-Diabetic Versus Diabetic Patients With First Acute Myocardial Infarction on Short- and Long-Term Mortality (from the MONICA/KORA Augsburg Myocardial Infarction Registry)

American Journal of Cardiology

Volumn 104, Issue 12, 2009, Pages 1607-1612

  Beck, Judith A ^a,b   Meisinger, Christa ^b,c   Heier, Margit ^b,c   Kuch, Bernhard ^c   Hörmann, Allmut ^b   Greschik, Claudia ^b,c   Koenig, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CASE FATALITY; CORRELATION ANALYSIS; DIABETIC PATIENT; DISEASE REGISTRY; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 70749158128     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.040     Document Type: Article

References (24)

1. Rydén L., Strandl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.J., Cosentino F., Jonsson B., Laakso M., Malmber K., Priori S., Östergreen J., Tuomilehto J., and Thrainsdottir I. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary-the Task Force of Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28 (2007) 88-136
2. Otter W., Kleybrink S., and Doehring W. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med 21 (2004) 183-187
3. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., Cox J.L., and ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
4. Schiele F., Descotes-Genon V., Seronde M.F., Blonde C., Legalery P., Meneveau N., Escarnot F., Mercier M., Penfornis A., Thebault L., Boumal D., and Bassand J.P. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med 23 (2006) 1370-1376
5. Aronson D., Hammerman H., Kapeliovich M.R., Suleiman A., Agmon Y., Beyar R., Markiewcz W., and Suleiman M. Fasting glucose in acute myocardial infarction-incremental value for long-term mortality and relationship with left ventricular systolic function. Diabetes Care 30 (2007) 960-966
6. Ainla T., Barburin A., Teesalu R., and Rahu M. The association between hyperglycemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 22 (2005) 1321-1325
7. Goldberg R.J., Kramer D.G., Lessard D., Yarzebski J., and Gore J.M. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis 18 (2007) 125-131
8. Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang Y., Havranek E.P., and Krumholz H.M. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
9. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
10. Bolk J., van der Ploeg T., Cornel J.H., Arnold A.E., Sepers J., and Umans V.A. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79 (2001) 207-214
11. Meier J.J., Deifuss S., Klamann A., Launhardt V., Schmiegel W.H., and Nauck M.A. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care 28 (2005) 2551-2553
12. Stranders I., Diamant M., van Gelder R.E., Spruijt H.J., Twisk J.W., Heine R.J., and Visser F.C. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 64 (2004) 982-988
13. Meisinger C., Hörmann H., Heier M., Kuch B., and Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusions era. Int J Cardiol 113 (2006) 229-235
14. Kuch B., von Scheidt W., Kling B., Heier M., Hörmann A., and Meisinger C. Characteristics and outcome of patients with acute myocardial infarction according to presenting electrocardiogram (from the MONICA/KORA Augsburg myocardial infarction - registry). Am J Cardiol 100 (2007) 1056-1060
15. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
16. Wong V.W., Ross D.L., Park K., Boyages S.C., and Cheung N.W. Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res Clin Pract 64 (2004) 85-91
17. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., Umemura T., Nakamura S., and Yoshida M. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 146 (2003) 674-678
18. Foo K., Cooper J., Deaner A., Knight C., Suliman A., Ranjadayalan K., and Timmis A.D. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
19. Deedwania P., Kosiborod M., Brrett E., Ceriello A., Isley W., Mazzone T., and Saskin P. Hyperglycemia and acute coronary syndrome. A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117 (2008) 1010-1019
20. Tansey M.J.B., and Opie L.H. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol 2 (1986) 326-331
21. Kosuge M., Kimura K., Kojima S., Sakamoto T., Matsui K., Ishihara M., Asasa Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., Inoue T., Saito F., Ogawa H., and Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circulation 69 (2005) 375-379
22. Norhammar A., Rydén L., and Malmberg K. Admission plasma glucose-independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care 22 (1999) 1827-1831
23. Pittas A.G., Siegel R.D., and Lau J. Insulin therapy for critically ill hospitalized patients. Arch Intern Med 164 (2004) 2005-2011
24. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32 (2009) 1327-1334